Glaucoma: The Silent Thief of Sight — What You Need to Know
More than 4 million Americans have glaucoma — and nearly half don't know it. By the time most people notice symptoms, permanent vision loss has already begun. Here's why early detection is everything.
Glaucoma is one of the most common — and most preventable — causes of blindness in the world. Yet it earns a nickname that tells you everything you need to know about why it's so dangerous: the "silent thief of sight." In most cases, glaucoma causes no pain, no visible symptoms, and no early warning signs. It simply, quietly, steals your vision — often until the damage is irreversible.
The good news is that when caught early, glaucoma can be managed effectively, and most people who receive treatment are able to preserve the vision they have. The challenge is getting people in for the exams that make early detection possible.
"Glaucoma can be prevented with early treatment — but only if it's found. Most people with glaucoma have no symptoms until significant vision loss has already occurred." — American Academy of Ophthalmology, March 2026
GLAUCOMA IN AMERICA
4.2 million Americans are living with glaucoma (2022). Nearly 50% who have glaucoma don't know it. 1.5 million have vision-affecting glaucoma in the U.S. Glaucoma is the #2 leading cause of blindness worldwide.
A landmark 2024 study published in JAMA Ophthalmology — using CDC Vision Health Initiative data — found glaucoma prevalence in the U.S. is significantly higher than previously estimated.
WHAT IS GLAUCOMA?
Glaucoma is not a single disease — it's a group of eye conditions that damage the optic nerve, the critical structure that sends visual information from your eye to your brain. In most cases, this damage is caused by elevated pressure inside the eye, known as intraocular pressure (IOP).
Here's what happens: Your eye constantly produces aqueous humor that nourishes the structures inside the eye. In a healthy eye, this fluid flows out through a drainage angle at a rate that keeps internal pressure stable. In glaucoma, the drainage system becomes blocked or less efficient — fluid builds up, and pressure rises. That elevated pressure gradually compresses and damages the optic nerve — first destroying peripheral (side) vision, then central vision if untreated. Once optic nerve damage occurs, it cannot be reversed. Lost vision from glaucoma does not come back.
TYPES OF GLAUCOMA
-
Primary open-angle glaucoma (Most common) — The drainage angle looks normal but functions inefficiently. Fluid builds up slowly, increasing pressure over time. No pain or noticeable symptoms until significant vision is lost. The most prevalent form in the U.S.
-
Acute angle-closure glaucoma (Medical emergency) — The drainage angle becomes suddenly blocked, causing a rapid and dangerous spike in eye pressure. Symptoms are severe: eye pain, headache, nausea, blurred vision, halos around lights. Requires emergency treatment immediately.
-
Normal-tension glaucoma — Optic nerve damage occurs despite normal intraocular pressure. May be related to poor blood flow to the optic nerve. More common in people of Japanese descent and those with cardiovascular disease.
-
Secondary glaucoma — Develops as a result of another condition such as eye injury, inflammation, diabetes, or prolonged use of corticosteroids.
-
Congenital glaucoma — Present at birth due to improper development of the eye's drainage system. Symptoms in infants include cloudy eyes, excessive tearing, and sensitivity to light. Treated with surgery.
-
Chronic angle-closure glaucoma — A slower version of angle-closure glaucoma where the drainage angle closes gradually. May have mild or no symptoms early on.
RISK FACTORS FOR GLAUCOMA
• Age over 60 — Risk increases significantly with age. • Family history — Having a parent, sibling, or close relative with glaucoma raises your risk considerably. • Elevated intraocular pressure (IOP) — High eye pressure is the most significant modifiable risk factor. • Diabetes and hypertension — Both conditions affect blood vessels in and around the eye. • Long-term corticosteroid use — Prolonged use of steroid eye drops or systemic corticosteroids can elevate intraocular pressure. • Severe nearsightedness (myopia) — High levels of myopia are associated with increased risk of open-angle glaucoma. • Eye injury or prior surgery — Past trauma to the eye can disrupt the drainage system.
Glaucoma and health equity: Non-Hispanic Black adults have the highest rates of glaucoma in the United States — nearly twice the prevalence of white adults — and are more than twice as likely to have vision-affecting glaucoma. Hispanic adults are also disproportionately affected. These disparities reflect broader inequities in access to preventive eye care.
SYMPTOMS — AND WHY MOST PEOPLE HAVE NONE
In its most common form, there are no symptoms. No pain. No redness. No blurred vision in the early stages. The first sign most people notice — peripheral vision loss — typically occurs only after significant optic nerve damage has already taken place.
Open-angle glaucoma is completely symptom-free in its early stages. By the time you notice changes in your vision, irreversible damage may already have occurred. Routine eye exams — not symptoms — are the primary means of detection.
Emergency symptoms of acute angle-closure glaucoma: sudden severe eye pain, headache, nausea or vomiting, blurred vision, and halos around lights. This is a medical emergency — go to an emergency room or ophthalmologist immediately.
HOW GLAUCOMA IS DETECTED
Glaucoma can only be reliably diagnosed through a comprehensive dilated eye exam. A full evaluation includes:
-
Tonometry — measuring eye pressure. A quick, painless test that measures the intraocular pressure (IOP) in your eye.
-
Ophthalmoscopy — examining the optic nerve. Your doctor dilates your pupils and examines the optic nerve directly for signs of damage.
-
Visual field test — mapping peripheral vision. A perimetry test maps your entire field of vision to detect any loss in peripheral sight.
-
OCT imaging — measuring nerve fiber thickness. Optical coherence tomography provides detailed cross-sectional images of the optic nerve, detecting even subtle thinning before vision loss occurs.
-
Gonioscopy — evaluating the drainage angle. A specialized lens exam allowing the doctor to see the drainage angle directly.
TREATMENT OPTIONS
There is currently no cure for glaucoma, and vision lost to the condition cannot be restored. However, treatment can effectively lower eye pressure and slow or halt further damage.
• Prescription eye drops — The most common first-line treatment. Various classes of drops reduce IOP by either decreasing fluid production or improving drainage. • Oral medications — Carbonic anhydrase inhibitors may be prescribed when drops alone are insufficient. • Laser therapy — Selective laser trabeculoplasty (SLT) and other laser procedures improve fluid drainage and can reduce the need for daily eye drops. • Minimally invasive glaucoma surgery (MIGS) — Micro-scale surgical procedures that improve drainage with less risk and faster recovery. Often performed alongside cataract surgery. • Conventional surgery (trabeculectomy) — Creates a new drainage pathway for fluid. Reserved for more advanced cases.
25% of glaucoma patients discontinue their eye drops due to side effects. If you're experiencing side effects from your glaucoma medication, talk to your ophthalmologist. Do not stop treatment without speaking to your doctor first.
THE MOST IMPORTANT THING YOU CAN DO
If you're over 40, have a family history of glaucoma, have diabetes, or belong to a population at higher risk — including Black and Hispanic adults — talk to your eye doctor about a comprehensive glaucoma screening. The American Academy of Ophthalmology recommends a baseline eye exam at 40, with follow-up frequency guided by your individual risk profile.
Glaucoma is not inevitable, and blindness from glaucoma is largely preventable. But prevention requires one thing above all else: showing up for the exam before symptoms begin.
This article is for informational purposes only and does not constitute medical advice. Sources: American Academy of Ophthalmology (March 2026), Cleveland Clinic, CDC Vision Health Data (VEHSS 2022), JAMA Ophthalmology, Glaucoma Research Foundation, Prevent Blindness, Ophthalmology Advisor.
